Vallon Pharmaceuticals Adjourns Special Meeting of Stockholders Until April 20, 2023

Board of Directors unanimously recommend Vallon stockholders to vote “FOR” all proposals outlined in the Company’s definitive Proxy Statement (the “Proxy”) in order to close the proposed merger with GRI Bio, Inc.